Dr Kenneth Baillie
Sepsis Research FEAT is absolutely delighted to report that GenOMICC’s chief investigator Dr Kenneth Baillie was last week awarded a Pride of Scotland Special Recognition Award.
The award was made in recognition of the hugely important work done by Dr Baillie, an Academic Consultant in Critical Care Medicine and Senior Research Fellow at the University of Edinburgh’s Roslin Institute, in the fight against COVID-19, heading up vital studies and contributing to the trial which found the first effective treatment for the disease.
The team at Roslin has worked tirelessly since the beginning of the pandemic when the GenOMICC study was granted Urgent Public Health Research status by the National Institute of Health Research (NIHR). It was subsequently given significant funding by Genomics England, UK Research and Innovation, the Department of Health and Social Care, and the NIHR.
From the platform established with the help of Sepsis Research FEAT prior to the pandemic the team was able to go on to recruit 212 ICUs across the UK to the GenOMICC study. They have now received over 14,000 samples of patient DNA for analysis and sequencing which has enabled them to make findings in both the understanding of COVID-19 as well as identifying appropriate treatment.
We are delighted that Dr Baillie has received the widespread public recognition that he so deserves and send warmest congratulations from the whole team here at Sepsis Research FEAT.